Business
Press Release Dec 03 2021
Sun Pharma Advanced Research Company Limited has informed the Exchange regarding a press release dated December 03, 2021, titled "SPARC enters into a licensing agreement with Biomodifying to acquire exclusive rights for antibody against unique oncology target.".
About this update from Sun Pharma Advanced Research Co. Ltd.
[{"type":"text","content":" Sun Pharma Advanced Research Company Limited has informed the Exchange regarding a press release dated December 03, 2021, titled \"SPARC enters into a licensing agreement with Biomodifying to acquire exclusive rights for antibody against unique oncology target.\". View Attachment","length":410,"tagName":"div"}]